Srivastava Leads Research at New England Peptide

Mass High Tech

 

February 16, 2009

 

By Ernie King - News Staff Writer

New England Peptide LLC has appointed former NEP board member Ved Srivastava as vice president for research production, where he will oversee the company production pipeline, officials reported.

Srivastava joins NEP from his former role as associate director of discovery research at Amylin Pharmaceuticals Inc. In that role, he led the discovery, synthesis and development of peptide hormones used for obesity, diabetes and neuropsychiatric treaments. His chemistry management skills also led Srivastava to direct research for Psylin Neurosciences Inc., the joint venture of Amylin and PsychoGenesis Inc.

Srivastava graduated from India’s University of Lucknow with a doctoral degree in organic chemistry. Since then, he’s held post-doctoral roles at the University of Georgia and the University of Colorado medical school.

Founded in 1998, Gardner-based NEP makes peptides used globally in drug and vaccine antibodies.


http://www.masshightech.com/stories/2009/02/16/daily10-Srivastava-leads-research-at-New-Englan-Peptide.html

Testimonials

"Over the past 8 years we have used NEP for synthesis of many hundreds of peptides. The quality of NEP’s product is consistently very high. The company is deeply knowledgeable in all aspects of peptide synthesis, highly collaborative, and keenly interested in meeting the changing needs of their customers with respect to scale and formatting for delivery of peptides. One example is their flash-purified product which meets the need for initial draft-level evaluation without breaking the bank. Our experience with NEP’s antibody production capabilities has also been very good..."
Steven Carr, PhD - Director of Proteomics, Broad Institute